Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells.
Amino Acid Transport System A
/ genetics
Amino Acids, Neutral
/ metabolism
Cell Culture Techniques
/ methods
Cell Membrane
/ metabolism
Cells, Cultured
Culture Media
/ chemistry
Fibroblasts
/ cytology
Glutamine
/ metabolism
Humans
Mesenchymal Stem Cells
/ cytology
Proline
/ metabolism
Protein Transport
beta-Alanine
/ analogs & derivatives
MeAIB
SNAT1
System A
adaptive regulation
amino acid starvation
cell volume
glutamine
hypertonic stress
mesenchymal stem cells
proline
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Mar 2020
10 Mar 2020
Historique:
received:
04
02
2020
revised:
07
03
2020
accepted:
09
03
2020
entrez:
14
3
2020
pubmed:
14
3
2020
medline:
15
12
2020
Statut:
epublish
Résumé
In cultured human fibroblasts, SNAT transporters (System A) account for the accumulation of non-essential neutral amino acids, are adaptively up-regulated upon amino acid deprivation and play a major role in cell volume recovery upon hypertonic stress. No information is instead available on the expression and activity of SNAT transporters in human bone marrow mesenchymal stromal cells (MSC), although they are increasingly investigated for their staminal and immunomodulatory properties and used for several therapeutic applications. The uptake of glutamine and proline, two substrates of SNAT1 and SNAT2 transporters, was measured in primary human MSC and an MSC line. The amino acid analogue MeAIB, a specific substrate of these carriers, has been used to selectively inhibit SNAT-dependent transport of glutamine and, through its sodium-dependent transport, as an indicator of SNAT1/2 activity. SNAT1/2 expression and localization were assessed with RT-PCR and confocal microscopy, respectively. Cell volume was assessed from urea distribution space. In all these experiments, primary human fibroblasts were used as the positive control for SNAT expression and activity. Compared with fibroblasts, MSC have a lower SNAT1 expression and hardly detectable membrane localization of both SNAT1 and SNAT2. Moreover, they exhibit no sodium-dependent MeAIB uptake or MeAIB-inhibitable glutamine transport, and exhibit a lower ability to accumulate glutamine and proline than fibroblasts. MSC exhibited an only marginal increase in MeAIB transport upon amino acid starvation and did not recover cell volume after hypertonic stress. In conclusion, the activity of SNAT transporters is low in human MSC. MSC adaptation to amino acid shortage is expected to rely on intracellular synthesis, given the absence of an effective up-regulation of the SNAT transporters.
Identifiants
pubmed: 32164327
pii: ijms21051899
doi: 10.3390/ijms21051899
pmc: PMC7084684
pii:
doi:
Substances chimiques
Amino Acid Transport System A
0
Amino Acids, Neutral
0
Culture Media
0
SLC38A1 protein, human
0
SLC38A2 protein, human
0
Glutamine
0RH81L854J
beta-Alanine
11P2JDE17B
2,2-dimethyl-beta-alanine
19036-43-2
Proline
9DLQ4CIU6V
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 20299
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 23354
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 19272
Références
Neuroscience. 2008 Apr 22;153(1):95-107
pubmed: 18358621
Amino Acids. 1996 Jun;11(2):117-33
pubmed: 24178683
PLoS One. 2016 Jun 07;11(6):e0156551
pubmed: 27272177
J Biol Chem. 1994 Apr 8;269(14):10485-91
pubmed: 8144632
J Biol Chem. 2005 Mar 11;280(10):8974-84
pubmed: 15632147
Pflugers Arch. 2004 Feb;447(5):784-95
pubmed: 12845534
J Cell Physiol. 2020 Jan;235(1):349-363
pubmed: 31237701
Biochim Biophys Acta. 2004 Dec 15;1667(2):157-66
pubmed: 15581851
Cell Death Differ. 2015 Jul;22(7):1094-105
pubmed: 25857264
Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G887-G895
pubmed: 30160974
Front Pharmacol. 2018 Feb 07;9:63
pubmed: 29467657
J Biol Chem. 2006 Jun 30;281(26):17929-40
pubmed: 16621798
Int Rev Neurobiol. 2013;108:59-77
pubmed: 24083431
J Mol Endocrinol. 2000 Oct;25(2):169-93
pubmed: 11013345
Cell Mol Life Sci. 2019 Sep;76(17):3323-3348
pubmed: 31055643
Cell. 1999 Dec 23;99(7):769-80
pubmed: 10619430
Oncogene. 2010 Jan 21;29(3):313-24
pubmed: 19881548
Cancer Cell. 2013 Oct 14;24(4):450-65
pubmed: 24094812
Tissue Eng Part A. 2010 Dec;16(12):3623-34
pubmed: 20673134
Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R656-62
pubmed: 15539610
J Biol Chem. 1965 Sep;240(9):3609-16
pubmed: 5891075
Front Immunol. 2019 May 08;10:977
pubmed: 31139179
Biochim Biophys Acta. 2016 Oct;1863(10):2531-9
pubmed: 26724577
Front Oncol. 2020 Jan 09;9:1480
pubmed: 31998641
Am J Physiol. 1999 Apr;276(4):C865-72
pubmed: 10199817
Stem Cell Reports. 2013 Oct 10;1(4):307-21
pubmed: 24319666
J Biol Chem. 1981 Jun 10;256(11):5422-7
pubmed: 7240147
J Clin Invest. 2007 Apr;117(4):1049-57
pubmed: 17380207
Stem Cell Rev Rep. 2020 Jan 16;:
pubmed: 31950339
Perit Dial Int. 1999 Mar-Apr;19(2):119-23
pubmed: 10357181
Cell. 2009 Feb 6;136(3):521-34
pubmed: 19203585
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Int J Mol Sci. 2018 Apr 06;19(4):
pubmed: 29642388
Amino Acids. 2017 Apr;49(4):795-803
pubmed: 28161797
Cancer Res. 2013 May 15;73(10):2998-3006
pubmed: 23585457
Blood Cancer J. 2012 Oct 12;2:e94
pubmed: 23064742
Pflugers Arch. 2014 Jan;466(1):155-72
pubmed: 24193407
Am J Physiol Cell Physiol. 2001 Jun;280(6):C1465-74
pubmed: 11350742
J Neurochem. 2003 Apr;85(2):503-14
pubmed: 12675927
Biochim Biophys Acta. 1991 Dec 9;1070(2):305-12
pubmed: 1684912
Acta Physiol (Oxf). 2006 May-Jun;187(1-2):273-83
pubmed: 16734764
Int J Hematol. 2016 Feb;103(2):129-37
pubmed: 26662288